Advertisement
Organisation › Details
4BIO Ventures (4BIO Capital) (Group)
4BIO Capital is a London-based venture capital firm focused solely on the advanced therapies sector. 4BIO’s objective is to invest in, support, and grow early stage companies developing treatments in areas of high unmet medical need, with the ultimate goal of ensuring access to these potentially curative therapies for all patients. Specifically, it looks for viable, high-quality opportunities in cell and gene therapy, RNA-based therapy, targeted therapies, and the microbiome. *
Start | 2018-01-08 existent | |
Industry | finance | |
Industry 2 | BIOTECH | |
Person | Kuzmin, Dmitry (Dima) (4BIO Ventures 2019 Managing Partner) | |
Region | London, Greater London | |
Country | United Kingdom (GB) | |
Street | 78 Pall Mall | |
City | SW1Y 5ES London | |
Tel | +44-203-427-5500 | |
Address record changed: 2024-01-05 | ||
Basic data | Employees | n. a. |
�About Section� taken from web site of organisation on 09.09. | ||
Record changed: 2023-06-26 |
Advertisement
More documents for 4BIO Ventures (4BIO Capital) (Group)
- [1] ViaNautis Bio Ltd.. (11/13/23). "Press Release: ViaNautis Bio Announces $25 Million Series A Financing to Drive the Next Generation of Genetic Nanomedicines". Cambridge....
- [2] SparingVision S.A.S.. (10/21/20). "Press Release: SparingVision Raises €44.5 Million and Appoints Stéphane Boissel as Chief Executive Officer". Paris....
- [3] 4BIO Capital (4BIO Ventures Management Ltd.). (9/9/19). "Press Release: 4BIO Capital Raises $50 million in First Close of New Advanced Therapies Fund". London & Boston, MA....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top